IN201721047406A - - Google Patents
Info
- Publication number
- IN201721047406A IN201721047406A IN201721047406A IN201721047406A IN201721047406A IN 201721047406 A IN201721047406 A IN 201721047406A IN 201721047406 A IN201721047406 A IN 201721047406A IN 201721047406 A IN201721047406 A IN 201721047406A IN 201721047406 A IN201721047406 A IN 201721047406A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201721047406A IN201721047406A (ja) | 2017-12-30 | 2018-12-29 | |
PCT/IB2018/060716 WO2019130277A1 (en) | 2017-12-30 | 2018-12-29 | Pharmaceutical formulations of azilsartan medoxomil |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201721047406A IN201721047406A (ja) | 2017-12-30 | 2018-12-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN201721047406A true IN201721047406A (ja) | 2020-06-19 |
Family
ID=65278423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN201721047406A IN201721047406A (ja) | 2017-12-30 | 2018-12-29 |
Country Status (2)
Country | Link |
---|---|
IN (1) | IN201721047406A (ja) |
WO (1) | WO2019130277A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022123592A1 (en) * | 2020-12-08 | 2022-06-16 | Alkem Laboratories Ltd | Stable pharmaceutical composition of azilsartan medoxomil or pharmaceutical acceptable salt and processes for preparing thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022182778A1 (en) * | 2021-02-24 | 2022-09-01 | Nostrum Pharmaceuticals, Llc | Pharmaceutical packages and methods of reducing formation of n-nitrosodimethylamine |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL102183A (en) | 1991-06-27 | 1999-11-30 | Takeda Chemical Industries Ltd | The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them |
US7157584B2 (en) | 2004-02-25 | 2007-01-02 | Takeda Pharmaceutical Company Limited | Benzimidazole derivative and use thereof |
WO2006076097A2 (en) * | 2004-12-07 | 2006-07-20 | Nektar Therapeutics | Stable non-crystalline formulation comprising losartan |
JP5047156B2 (ja) | 2006-02-27 | 2012-10-10 | 武田薬品工業株式会社 | 医薬パッケージ |
JP5361188B2 (ja) | 2006-08-10 | 2013-12-04 | 武田薬品工業株式会社 | 医薬組成物 |
EP2068812B9 (en) | 2006-09-25 | 2012-08-08 | Takeda Pharmaceutical Company Limited | Medicinal package |
MX2009010167A (es) | 2007-03-28 | 2009-10-12 | Takeda Pharmaceutical | Composicion farmaceutica solida que comprende un derivado de bencimidazol-7-carboxilato y un agente para el control del ph. |
JP2014515359A (ja) * | 2011-05-23 | 2014-06-30 | ジエンス ヘンルイ メデイシンカンパニー リミテッド | ベンズイミダゾール誘導体を含む固形医薬組成物 |
WO2014102628A1 (en) | 2012-12-31 | 2014-07-03 | Ranbaxy Laboratories Limited | Stable pharmaceutical composition comprising azilsartan medoxomil |
US20160008328A1 (en) * | 2014-07-11 | 2016-01-14 | Cadila Healthcare Limited | Stable Pharmaceutical Package Comprising Azilsartan Medoxomil |
CN105456210A (zh) * | 2015-12-10 | 2016-04-06 | 合肥久诺医药科技有限公司 | 一种高生物利用度的阿齐沙坦组合物 |
CN106074416A (zh) * | 2016-08-30 | 2016-11-09 | 佛山市弘泰药物研发有限公司 | 一种阿齐沙坦酯钾盐分散片的制备方法 |
-
2018
- 2018-12-29 IN IN201721047406A patent/IN201721047406A/en unknown
- 2018-12-29 WO PCT/IB2018/060716 patent/WO2019130277A1/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022123592A1 (en) * | 2020-12-08 | 2022-06-16 | Alkem Laboratories Ltd | Stable pharmaceutical composition of azilsartan medoxomil or pharmaceutical acceptable salt and processes for preparing thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2019130277A1 (en) | 2019-07-04 |